1. Predictive molecular biomarkers to guide clinical decision making in kidney cancer: current progress and future challenges
   Jason Yongsheng Chan et al, 2015, Expert Review of Molecular Diagnostics CrossRef
2. Ang-(1-7) promotes the migration and invasion of human renal cell carcinoma cells via Mas-mediated AKT signaling pathway
   Shuai Zheng et al, 2015, Biochemical and Biophysical Research Communications CrossRef
3. A decade of pharmacogenomics research on tyrosine kinase inhibitors in metastatic renal cell cancer: a systematic review
   Meta H. M. Diekstra et al, 2016, Expert Review of Molecular Diagnostics CrossRef
4. TKIs in Renal Cell Carcinoma
   Jolanda J. Schoon et al, 2019, Oncogenomics CrossRef
5. Sub-classification of patients with intermediate-risk metastatic renal cell carcinoma treated with targeted therapy
   Go Kaneko et al, 2019, Japanese Journal of Clinical Oncology CrossRef
6. Prognostic Biomarkers for Response to Vascular Endothelial Growth Factor–Targeted Therapy for Renal Cell Carcinoma
   Andrew G. Winer et al, 2016, Urologic Clinics of North America CrossRef